Novogene Co., Ltd. (SHA:688315)
China
· Delayed Price · Currency is CNY 14.08
+0.30 (2.18%)
Apr 29, 2025, 1:45 PM CST
Novogene Market Cap
Novogene has a market cap or net worth of 5.58 billion as of April 28, 2025. Its market cap has decreased by -5.22% in one year.
Market Cap
5.58B
Enterprise Value
4.15B
Revenue
2.14B
Ranking
n/a
PE Ratio
28.35
Stock Price
14.08
Market Cap Chart
Since April 13, 2021, Novogene's market cap has decreased from 10.97B to 5.58B, a decrease of -49.10%. That is a compound annual growth rate of -15.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 5.58B | 10.24% |
| Dec 31, 2024 | 5.06B | -47.88% |
| Dec 29, 2023 | 9.71B | -8.02% |
| Dec 30, 2022 | 10.56B | -36.10% |
| Dec 31, 2021 | 16.53B | 50.73% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 319.64B |
| Shenzhen Mindray Bio-Medical Electronics | 262.45B |
| WuXi AppTec | 163.06B |
| Zhangzhou Pientzehuang Pharmaceutical., | 124.34B |
| Aier Eye Hospital Group | 121.89B |
| Sichuan Biokin Pharmaceutical | 111.04B |
| Shanghai United Imaging Healthcare | 104.35B |
| Yunnan Baiyao Group Co.,Ltd | 103.31B |